Infection Control Today Magazine - healthcare-acquired infections (HAIs), hospital infections, infection prevention and control, healthcare epidemiology, aseptic technique, environmental hygiene, hand hygiene, disinfection and sterilization, outbreak investigation, surveillance

FEATURES

Infection Control Tomorrow

Learn more about Infection Control Tomorrow, the industry's most progressive 2-day in-person event discussing traditional strategies and leading ...read more

Science Summit: Emerging Pathogens

The Science Summits provide an opportunity for manufacturers in the infection prevention and control arena to present and explain the science behind ...read more

The Volatile World of Influenza Viruses

The current global influenza situation is characterized by a number of trends that must be closely monitored. These include: an increase in the ...read more

Clostridium difficile Infections

Clostridium difficile (C. difficile) caused almost half a million infections among patients in the United States in a single year, according to a ...read more

Preoperative CHG Bathing

This report addresses patient skin cleansing with chlorhexidine gluconate (CHG) as an effective intervention in the arsenal against surgical site ...read more

Latest Headlines

Use of Gastric Acid-Suppressive Agents Linked With Diarrhea Infection

Use of gastric acid-suppressive therapy, particularly proton pump inhibitors, is associated with an increased risk for an infection that is a significant cause of diarrhea, according to a study in the Dec. 21, 2005 issue of JAMA. Clostridium difficile infection, an ...More
December 21, 2005 Posted in News
Socioeconomic Status Doesn't Explain Racial Gap in Vaccine Rates

Elderly blacks and Hispanics are vaccinated against flu and pneumonia at levels 15 percent to 22 percent below whites, but the reason is not simply due to income, education or access to health care, two new studies reveal. The influenza vaccine and pneumonia shot are both ...More
December 20, 2005 Posted in News
New Antibiotic Candidate Shows Promise in Treating Clostridium Difficile-Associated Diarrhea

SPRING VALLEY, N.Y. -- Studies presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, D.C., showed that PAR-101 was potentially efficacious in treating C. difficile-associated diarrhea (CDAD). According to Centers for ...More
December 19, 2005 Posted in News
2005 is a Landmark Year for Adolescent Vaccines; Progress Paves the Way for Improved Protection

NEW YORK -- In the world of disease prevention, adolescents have traditionally gotten short shrift from the medical community. For years, adolescents have had little in the way of vaccine protection, but the year 2005 brought with it new vaccines for this age group, with ...More
December 19, 2005 Posted in News
Scientist Identifies Genetic Mutation Linked to TB

Results from a study indicate that a small mutation in a particular gene increases a person’s odds of developing active tuberculosis, said Pedro Flores-Villanueva, MD, assistant professor of immunology at the University of Texas Health Center at Tyler. “A large number of ...More
December 19, 2005 Posted in News
Sanofi Pasteur Announces Preliminary Trial Results for a First H5N1 Pre-Pandemic Influenza Vaccine Candidate With an Adjuvant

LYON, France -- Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced that preliminary results of clinical trials fielded in France of an adjuvanted candidate H5N1 pre-pandemic influenza vaccine demonstrated a good immune response in a significant ...More
December 19, 2005 Posted in News
FDA Warns Consumers to Avoid Drinking Raw Milk

Following an outbreak in the state of Washington, the Food and Drug Administration (FDA) is warning the public against drinking raw milk because it may contain harmful bacteria that can cause life-threatening illnesses. Raw milk is not treated or pasteurized to remove ...More
December 19, 2005 Posted in News
Single-Day Famvir Treatment Found to Shorten the Duration of Recurrent Genital Herpes Outbreaks

WASHINGTON, D.C. -- Results from a new study demonstrated that a single day of treatment with the antiviral Famvir (famciclovir) stopped the progression to a full outbreak or shortened the duration of an outbreak in patients with recurrent genital herpes (RGH). With the ...More
December 19, 2005 Posted in News
First in New Class of Antibacterials Demonstrates Promising Activity Against Pathogens Commonly Found in Skin Infections

WASHINGTON, D.C. -- Studies presented today demonstrated that GlaxoSmithKline's investigational antibacterial retapamulin showed an excellent microbiology profile and a high degree of in vitro potency in laboratory studies against key pathogens commonly associated with skin ...More
December 19, 2005 Posted in News
FDA Rules Anthrax Vaccine Safe and Effective to Prevent Anthrax Regardless of Route of Exposure

GAITHERSBURG, Md. -- Emergent BioSolutions Inc. announced today that the Food and Drug Administration (FDA) has issued a Final Order confirming that the company's anthrax vaccine, BioThrax, is safe and effective for immunization against anthrax infection, regardless of the ...More
December 16, 2005 Posted in News